FOLLICULITIS DECALVANS (FD)

Clinical trials for FOLLICULITIS DECALVANS (FD) explained in plain language.

Never miss a new study

Get alerted when new FOLLICULITIS DECALVANS (FD) trials appear

Sign up with your email to follow new studies for FOLLICULITIS DECALVANS (FD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for painful, scarring scalp disease that defies antibiotics

Disease control Not yet recruiting

This study is testing three different biologic drugs (adalimumab, ustekinumab, and baricitinib) to see if they can control painful flare-ups of folliculitis decalvans, a rare condition that causes scarring hair loss. It is for adults whose disease has not been controlled by at le…

Matched conditions: FOLLICULITIS DECALVANS (FD)

Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control

Last updated Apr 02, 2026 03:57 UTC

FOLLICULITIS DECALVANS (FD)

Get alerted when new FOLLICULITIS DECALVANS (FD) trials appear

New hope for painful, scarring scalp disease that defies antibiotics